rash from tirzepatide shot Severe reaction to injection What to do about suspected

But GLP-1 agonists, such as Ozempic, are not just transforming healthcare

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lillys tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs

Extremely high pricing (over $350 monthly) indicates excessive markup without corresponding value

To reduce sugar content, many brands use alternative sweeteners like stevia, monk fruit or erythritol, which don't spike blood sugar the same way traditional sugar does

This expands demand beyond active users by roughly 50% in the US

Instead, always use a secure container designed for sharp objects